Sopartec

Sopartec functions as the technology transfer and investment arm of the Université catholique de Louvain (UCLouvain). Operating within its Louvain Technology Transfer Office (LTTO), it commercializes academic research from UCLouvain and affiliated medical institutions. This occurs via spin-off creation and intellectual property licensing agreements. Sopartec also co-manages the VIVES Investment Funds, directing capital into promising UCLouvain-derived ventures.

Established by UCLouvain, Sopartec reflects the institution's commitment to translating scientific discovery into commercial impact. Its formation arose from a strategic insight into fostering economic growth from pioneering research developed within the university and its clinical partners. An integral part of UCLouvain’s innovation ecosystem, it effectively commercializes intellectual property and catalyzes new ventures rooted in academic advancement rather than being founded by individual entrepreneurs.

Sopartec supports university researchers, emerging startup teams, and industrial partners seeking advanced intellectual property. The organization propels research outcomes from laboratory to marketplace, fostering a dynamic innovation landscape. Its overarching vision, articulated as "making science investable," transforms scientific breakthroughs into tangible businesses, thereby contributing to economic development and addressing pressing societal needs.